-
51 7.73
Distinct IL-1/VEGF-Dominant Phenotype in IL-6-Refractory Multicentric Castleman Disease: A Pooled Matched Analysis of Anakinra versus IL-6 Blockade
-
52 6.4
Steroid Non-Response Predicts IL-6 Blockade Failure and Defines a Non-IL-6-Dominant Inflammatory Subset in TAFRO Syndrome: A Pooled Patient-Level Analysis
-
64 4.9
Clinical Predictors of Remission in TAFRO Syndrome: A Pooled Meta Analysis of 70 Published Cases